Content Tagged Duane Mitchell Subscribe to RSS Feed

Mitchell thumbnail

Sept. 21: Dr. Duane Mitchell speaks at Biden Cancer Summit & team hosts Biden Cancer Community Summit

Published: Sep 17th, 2018

Watch Dr. Duane Mitchell’s talk at the Biden Cancer Summit live — and tune into talks from other UF Brain Tumor Immunotherapy Program team members leading up to it.

McCain 1

Dr. Duane Mitchell discusses glioblastoma in The Conversation

Published: Aug 27th, 2018

On Saturday, Aug. 25, Sen. John McCain lost his courageous year-plus battle with glioblastoma. Dr. Duane Mitchell discusses the disease and his hope for future research breakthroughs.

HOH 1

Dr. Brian Hoh named chair of neurosurgery

Published: Jun 27th, 2018

Brian Hoh, M.D., an internationally known expert in the treatment of brain aneurysms, brain arteriovenous malformations, and ischemic and hemorrhagic stroke, will lead the department of neurosurgery.

BTD3

May 12: UF Brain Tumor Education Day

Published: Apr 7th, 2018

UF Brain Tumor Education Day will offer patients with brain tumors and caregivers the opportunity to learn about treatment options and resources available at UF Health.

BTIP team honored at annual SNO meeting

Published: Nov 20th, 2017

A strong showing by the Brain Tumor Immunotherapy Program team at this year’s Society for Neuro-Oncology meeting included a Top 5 Poster Award for Drs. Loic Deleyrolle and Lan Hoang-Minh.

Explore More: Innovation in Immunotherapy

Published: Mar 16th, 2017

Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer […]

Immunotherapy for brain cancer

Published: Jun 1st, 2016

Duane Mitchell, M.D., Ph.D., co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy and director of the UF Brain Tumor Immunotherapy Program in the MBI, discusses his research […]

Brain Cancer

Brain Cancer

Published: Nov 1st, 2011

Brain tumors, which are abnormal growths of cells within the brain, can be cancerous (malignant) and spread if not properly addressed. More than 200,000 people in the U.S. receive the […]